Evidence map›Paper›PMID 37060042›Full record

ArticleJournal of animal science and biotechnology2023

Mannan oligosaccharides alleviate oxidative injury in the head kidney and spleen in grass carp (Ctenopharyngodon idella) via the Nrf2 signaling pathway after Aeromonas hydrophila infection.

Zhiyuan Lu, Lin Feng, Weidan Jiang, Pei Wu, Yang Liu, Jun Jiang, Shengyao Kuang, Ling Tang, Shuwei Li, Chengbo Zhong and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of animal science and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ameliorative effect of BIO-MOSOpen veterinary journal · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Zhiyuan LuAnimal Nutrition Institute, Sichuan Agricultural University, Chengdu, 611130, China.
Lin FengAnimal Nutrition Institute, Sichuan Agricultural University, Chengdu, 611130, China.
Weidan JiangAnimal Nutrition Institute, Sichuan Agricultural University, Chengdu, 611130, China.
Pei WuAnimal Nutrition Institute, Sichuan Agricultural University, Chengdu, 611130, China.
Yang LiuAnimal Nutrition Institute, Sichuan Agricultural University, Chengdu, 611130, China.
Jun JiangAnimal Nutrition Institute, Sichuan Agricultural University, Chengdu, 611130, China.
Shengyao KuangSichuan Animal Science Academy, Sichuan Animtech Feed Co. Ltd, Chengdu, 610066, China.
Ling TangSichuan Animal Science Academy, Sichuan Animtech Feed Co. Ltd, Chengdu, 610066, China.
Shuwei LiSichuan Animal Science Academy, Sichuan Animtech Feed Co. Ltd, Chengdu, 610066, China.
Chengbo ZhongSichuan Animal Science Academy, Sichuan Animtech Feed Co. Ltd, Chengdu, 610066, China.
Xiaoqiu ZhouAnimal Nutrition Institute, Sichuan Agricultural University, Chengdu, 611130, China. zhouxq@sicau.edu.cn.
Sichuan Agricultural University · CNSichuan Animal Science Academy · CN

Funding

CARS (CARS-45) CARS (CARS-45)National Outstanding Youth Science Fund Project of National Natural Science Foundation of China 31922086Sichuan Province Science and Technology Support Program 2019YFN0036the National Key R&D Program of China 2018YFD0900400the National Key R&D Program of China 2019YFD0900200the Young Top-Notch Talent Support Program the Young Top-Notch Talent Support Program
6 · The paper itself

Abstract

backgroundMannan oligosaccharides (MOS) are recommended as aquaculture additives owing to their excellent antioxidant properties. In the present study, we examined the effects of dietary MOS on the head kidney and spleen of grass carp (Ctenopharyngodon idella) with Aeromonas hydrophila infection.

methodsA total of 540 grass carp were used for the study. They were administered six gradient dosages of the MOS diet (0, 200, 400, 600, 800, and 1,000 mg/kg) for 60 d. Subsequently, we performed a 14-day Aeromonas hydrophila challenge experiment. The antioxidant capacity of the head kidney and spleen were examined using spectrophotometry, DNA fragmentation, qRT-PCR, and Western blotting.

resultsAfter infection with Aeromonas hydrophila, 400-600 mg/kg MOS supplementation decreased the levels of reactive oxygen species, protein carbonyl, and malonaldehyde and increased the levels of anti-superoxide anion, anti-hydroxyl radical, and glutathione in the head kidney and spleen of grass carp. The activities of copper-zinc superoxide dismutase, manganese superoxide dismutase, catalase, glutathione S-transferase, glutathione reductase, and glutathione peroxidase were also enhanced by supplementation with 400-600 mg/kg MOS. Furthermore, the expression of most antioxidant enzymes and their corresponding genes increased significantly with supplementation of 200-800 mg/kg MOS. mRNA and protein levels of nuclear factor erythroid 2-related factor 2 also increased following supplementation with 400-600 mg/kg MOS. In addition, supplementation with 400-600 mg/kg MOS reduced excessive apoptosis by inhibiting the death receptor pathway and mitochondrial pathway processes.

conclusionsBased on the quadratic regression analysis of the above biomarkers (reactive oxygen species, malondialdehyde, and protein carbonyl) of oxidative damage in the head kidney and spleen of on-growing grass carp, the recommended MOS supplementation is 575.21, 557.58, 531.86, 597.35, 570.16, and 553.80 mg/kg, respectively. Collectively, MOS supplementation could alleviate oxidative injury in the head kidney and spleen of grass carp infected with Aeromonas hydrophila.

Indexed as

AntioxidantApoptosisFunctional organsGrass carpMannan oligosaccharides

Identifiers

PMID37060042
PMCPMC10105433
OpenAlexW4365503318

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.